Last Updated: June 26, 2026

CLINICAL TRIALS PROFILE FOR DOLUTEGRAVIR SODIUM; LAMIVUDINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DOLUTEGRAVIR SODIUM; LAMIVUDINE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT07336797 ↗	Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy	RECRUITING	Abdelrahman Mahmoud	PHASE2	2025-09-01	We investigate the role of empagliflozin in the treatment of obesity in PLWH.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DOLUTEGRAVIR SODIUM; LAMIVUDINE

Condition Name

Chart
Table

Condition Name for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Intervention	Trials
HIV (Human Immunodeficiency Virus)	1
Metabolic Syndrome	1
Obesity & Overweight	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Intervention	Trials
Overweight	1
Obesity	1
Metabolic Syndrome	1
Body Weight	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DOLUTEGRAVIR SODIUM; LAMIVUDINE

Trials by Country

Map
Table

Trials by Country for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Location	Trials
Egypt	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DOLUTEGRAVIR SODIUM; LAMIVUDINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Clinical Trial Phase	Trials
PHASE2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Clinical Trial Phase	Trials
RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DOLUTEGRAVIR SODIUM; LAMIVUDINE

Sponsor Name

Chart
Table

Sponsor Name for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Sponsor	Trials
Abdelrahman Mahmoud	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DOLUTEGRAVIR SODIUM; LAMIVUDINE
Sponsor	Trials
OTHER	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.